Bullfrog AI (BFRG) Short Interest Ratio & Short Volume

Short interest is the volume of Bullfrog AI shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 501,500 shares of BFRG short. 7.34% of Bullfrog AI's shares are currently sold short. Learn More on Bullfrog AI's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.34% of Bullfrog AI's floating shares are currently sold short.

Bullfrog AI saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 501,500 shares, an increase of 47.7% from the previous total of 339,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Bullfrog AI currently has issued a total of 9,415,000 shares. Some of Bullfrog AI's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bullfrog AI currently has a public float of 6,830,000 shares.

7.34% of Bullfrog AI's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bullfrog AI: BeyondSpring Inc. (6.28%), IO Biotech, Inc. (0.23%), Cabaletta Bio, Inc. (13.17%), Alto Neuroscience, Inc. (14.14%), Acumen Pharmaceuticals, Inc. (3.97%), Rani Therapeutics Holdings, Inc. (10.27%), Cyclacel Pharmaceuticals, Inc. (0.22%), Skye Bioscience, Inc. (14.88%), Applied Therapeutics, Inc. (15.14%), Achilles Therapeutics plc (1.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

Short selling BFRG is an investing strategy that aims to generate trading profit from Bullfrog AI as its price is falling. BFRG shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bullfrog AI occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BFRG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BFRG, twice per month. The most recent reporting period available is April, 15 2025.